Business

Results of the 2026 Annual General Meeting for the 2024/25 Financial Year of BRAIN Biotech AG

ZWINGENBERG, GERMANY - March 11, 2026 (NEWMEDIAWIRE) - At today's Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all agenda items with a broad majority. Dr. Ursu...

Brain Biotech AgMarch 11, 20264
Results of the 2026 Annual General Meeting for the 2024/25 Financial Year of BRAIN Biotech AG

About this update from Brain Biotech Ag

View the original release on www.newmediawire.com

View stock analysis, news, and events for Brain Biotech Ag

Frankfurt Stock ExchangeSupervisory BoardBRAIN Biotech AGAnnual General MeetingYour Biotech Experts PartnershipBiotech AGBiotech GroupUrsula La CognataMichael MajerusBRAIN Biotech Group

More from Brain Biotech Ag

All Brain Biotech Ag news →